US Stock MarketDetailed Quotes
GOSS Gossamer Bio
- 0.761
- +0.018+2.37%
Trading Apr 23 11:43 ET
171.58MMarket Cap-644P/E (TTM)
0.798High0.750Low209.95KVolume0.750Open0.743Pre Close162.89KTurnover0.11%Turnover RatioLossP/E (Static)225.58MShares1.88052wk High2.74P/B145.27MFloat Cap0.45352wk Low--Dividend TTM190.99MShs Float27.150Historical High--Div YieldTTM6.41%Amplitude0.453Historical Low0.775Avg Price1Lot Size
About Gossamer Bio Company
Gossamer Bio, Inc. engages in discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. Its primary product candidate, GB001, is intended for the treatment of moderate-to-severe eosinophilic asthma and other allergic conditions. The company was founded by Faheem Hasnain and Sheila Gujrathi in 2015 and is headquartered in San Diego, CA.
Company Profile
SymbolGOSS
Company NameGossamer Bio
Listing DateFeb 8, 2019
Issue Price16.00
Founded2015
CEOMr. Faheem Hasnain
MarketNASDAQ
Employees135
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address3013 Science Park Road,Suite 200
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92121
Phone1-858-684-1300
Websitehttp://www.gossamerbio.com
Company Executives
- Name
- Position
- Salary
- Faheem Hasnain
- Chairman of the Board, President and Chief Executive Officer
- 7.26M
- Bob Smith
- Chief Commercial Officer
- --
- Dr. Richard Aranda, M.D.
- Chief Medical Officer
- 2.48M
- Bryan Giraudo
- Chief Operating Officer, Chief Financial Officer and Principal Accounting officer
- 3.27M
- Caryn Peterson
- Executive Vice President, Regulatory Affairs
- --
- Christian Waage
- Executive Vice President, Technical Operations and Administration
- 2.06M
- Dr. Sandra Milligan, J.D.,M.D.
- Independent Director
- 197.22K
- Dr. John D. Quisel, J.D.,PhD
- Independent Director
- --
- Dr. Steven Nathan, M.D.
- Independent Director
- --
- Renee D. Gala
- Independent Director
- 210.22K
- Skye Drynan
- Independent Director
- --
- Russell J. Cox
- Independent Director
- 210.72K
- Dr. Thomas O. Daniel, M.D.
- Lead Independent Director
- 222.22K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg